HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yang Zhang Selected Research

pyruvate dehydrogenase kinase 4

1/2021Increased Expression of PDK4 Was Displayed in Gastric Cancer and Exhibited an Association With Glucose Metabolism.
1/2020Withdrawal: Transforming growth factor β mediates drug resistance by regulating the expression of pyruvate dehydrogenase kinase 4 in colorectal cancer.
12/2016Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yang Zhang Research Topics

Disease

513Neoplasms (Cancer)
11/2022 - 12/2002
114Infections
12/2022 - 12/2006
109Inflammation (Inflammations)
08/2022 - 01/2006
92Neoplasm Metastasis (Metastasis)
07/2022 - 01/2004
74Breast Neoplasms (Breast Cancer)
07/2022 - 08/2004
70Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 11/2004
61Carcinogenesis
01/2022 - 04/2008
54Hepatocellular Carcinoma (Hepatoma)
06/2022 - 03/2006
49Stomach Neoplasms (Stomach Cancer)
05/2022 - 12/2002
43Adenocarcinoma of Lung
03/2022 - 06/2011
37Atherosclerosis
06/2022 - 07/2008
36Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 07/2003
34Wounds and Injuries (Trauma)
05/2022 - 07/2002
34Carcinoma (Carcinomatosis)
08/2021 - 03/2006
31Pain (Aches)
05/2022 - 12/2005
30Body Weight (Weight, Body)
01/2022 - 03/2006
29Fibrosis (Cirrhosis)
04/2022 - 05/2009
28Hypoxia (Hypoxemia)
01/2022 - 09/2011
28Lung Neoplasms (Lung Cancer)
01/2022 - 06/2008
27COVID-19
01/2022 - 01/2020
27Obesity
01/2022 - 01/2009
26Hypertension (High Blood Pressure)
10/2022 - 10/2005
24Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2004
22Osteoporosis
05/2022 - 10/2011
22Nasopharyngeal Carcinoma
03/2022 - 01/2008
22Glioma (Gliomas)
01/2022 - 01/2013
21Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 07/2008
21Colonic Neoplasms (Colon Cancer)
04/2022 - 01/2002
21Neuralgia (Stump Neuralgia)
01/2021 - 08/2008
20Sepsis (Septicemia)
05/2022 - 01/2011
19Disease Progression
03/2022 - 12/2006
18Insulin Resistance
01/2022 - 11/2004
18Adenocarcinoma
01/2022 - 10/2007
18Necrosis
03/2021 - 07/2007
17Alzheimer Disease (Alzheimer's Disease)
06/2022 - 05/2014
16Prostatic Neoplasms (Prostate Cancer)
08/2022 - 07/2009
16Hemorrhage
05/2022 - 11/2011
16Reperfusion Injury
02/2022 - 08/2009
16Hyperalgesia
01/2022 - 02/2008
16Lymphatic Metastasis
01/2022 - 01/2011
15Non-alcoholic Fatty Liver Disease
08/2022 - 04/2015
15Bacterial Infections (Bacterial Infection)
02/2022 - 11/2008
15Squamous Cell Carcinoma of Head and Neck
01/2022 - 08/2004
15Virus Diseases (Viral Diseases)
12/2021 - 01/2012
14Diarrhea
08/2022 - 07/2003
14Stroke (Strokes)
07/2022 - 06/2011
14Heart Failure
03/2022 - 11/2007

Drug/Important Bio-Agent (IBA)

239Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2002
102Biomarkers (Surrogate Marker)IBA
06/2022 - 10/2008
88Pharmaceutical PreparationsIBA
08/2022 - 08/2007
86MicroRNAs (MicroRNA)IBA
05/2022 - 01/2012
61Messenger RNA (mRNA)IBA
04/2022 - 08/2004
59Biological ProductsIBA
10/2022 - 10/2008
47CytokinesIBA
05/2022 - 11/2008
47LipidsIBA
01/2022 - 07/2003
45Long Noncoding RNAIBA
05/2022 - 05/2014
34Therapeutic UsesIBA
02/2022 - 01/2002
33Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2004
31ErbB Receptors (EGF Receptor)IBA
01/2022 - 12/2006
28InflammasomesIBA
05/2022 - 01/2014
27LigandsIBA
01/2022 - 11/2009
26CholesterolIBA
11/2022 - 01/2013
26RNA (Ribonucleic Acid)IBA
08/2022 - 03/2010
25CollagenIBA
04/2022 - 07/2002
25EnzymesIBA
12/2021 - 01/2006
23Peptides (Polypeptides)IBA
01/2022 - 01/2013
23Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2010
23Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2004
22Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2013
22Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 07/2013
21DNA (Deoxyribonucleic Acid)IBA
10/2022 - 04/2007
21Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 12/2004
19Small Interfering RNA (siRNA)IBA
01/2022 - 10/2009
19Gefitinib (Iressa)FDA Link
01/2021 - 12/2006
18Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 12/2004
17AcidsIBA
11/2020 - 12/2005
16Indicators and Reagents (Reagents)IBA
04/2022 - 05/2011
16Matrix Metalloproteinases (MMPs)IBA
04/2022 - 06/2007
16AntigensIBA
02/2022 - 12/2010
16VaccinesIBA
01/2022 - 01/2013
16Insulin (Novolin)FDA Link
01/2022 - 05/2004
16Circular RNAIBA
01/2022 - 07/2017
16Phosphotransferases (Kinase)IBA
01/2022 - 01/2012
14LipopolysaccharidesIBA
05/2022 - 01/2012
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 06/2007
14Interleukin-6 (Interleukin 6)IBA
04/2022 - 10/2013
14ebosinIBA
01/2022 - 01/2006
14Oxygen (Dioxygen)IBA
01/2022 - 09/2003

Therapy/Procedure

211Therapeutics
12/2022 - 12/2003
92Drug Therapy (Chemotherapy)
09/2022 - 12/2003
27Immunotherapy
03/2022 - 04/2009
26Radiotherapy
02/2022 - 07/2010
21Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 02/2012
20Precision Medicine
06/2022 - 01/2017
19Aftercare (After-Treatment)
01/2022 - 12/2005
17Stents
10/2022 - 10/2005
17Lymph Node Excision (Lymph Node Dissection)
01/2022 - 03/2012
17Ligation
01/2022 - 09/2011
17Lasers (Laser)
10/2021 - 01/2008
15Length of Stay
01/2022 - 09/2013